Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7889115 | 0.88 | SMN1; SMN2 (0.56) | ALDH1A1TSHRACHEHPGDGAA | |
| SCHEMBL11705310 | 0.80 | CYP11B1 (0.56) | ALDH1A1POLB | |
| SCHEMBL6054861 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRACHEHPGDGAA | |
| SCHEMBL11255408 | 0.78 | MEN1 (0.47) | ALDH1A1TSHRHPGDGAAMEN1 | |
| SCHEMBL12511057 | 0.78 | ACHE (0.74) | ALDH1A1TSHRACHEMEN1POLB | |
| SCHEMBL3202573 | 0.78 | ALDH1A1 (0.72) | ALDH1A1TSHRACHEHPGDMEN1 | |
| SCHEMBL1696805 | 0.76 | ALDH1A1 (0.64) | ALDH1A1TSHRACHEHPGDMEN1 | |
| SCHEMBL301933 | 0.76 | ALDH1A1 (0.69) | ALDH1A1TSHRACHEHPGDMEN1 | |
| SCHEMBL27848284 | 0.76 | ALDH1A1 (0.58) | ALDH1A1TSHRACHEHPGDGAA | |
| SCHEMBL7114927 | 0.75 | ACHE (0.56) | ALDH1A1TSHRACHEHPGDCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102569896-B | Lithium ion secondary battery and preparation method thereof | BYD CO LTD | 2015-01-14 | — | — | CN | disclosed |
| CN-102569896-A | Lithium ion secondary battery and preparation method thereof | BYD CO LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-1889955-A | Tricyclic imidazopyridines for use as gastric secretion inhibitors | ALTANA PHARMA AG (DE) | 2007-01-03 | — | — | CN | disclosed |
| CN-1065244-C | Tricyclic benzazepine vasopressin antagonists | AMERICAN CYANAMID CO (US) | 2001-05-02 | — | — | CN | disclosed |
| CN-1056374-C | Tricyclic diazepine vasopression antagonists | AMERICAN CYANAMID CO (US) | 2000-09-13 | — | — | CN | disclosed |
| CN-1231666-A | Tricyclic benzazepine vasopressin antagonists | AMERICAN CYANAMID CO (US) | 1999-10-13 | — | — | CN | disclosed |
| CN-1205335-A | Tricyclic diazepine vasopression antagonists | AMERICAN CYANAMID CO (US) | 1999-01-20 | — | — | CN | disclosed |
| CN-1039908-C | Tricyclic diaza * vasopressin antagonists and oxytocin antagonists | AMERICAN CYANAMID CO (US) | 1998-09-23 | — | — | CN | disclosed |
| CN-1106812-A | Tricyclic diaza * vasopressin antagonists and oxytocin antagonists | AMERICAN CYANAMID CO (US) | 1995-08-16 | — | — | CN | disclosed |
| US-4362666-A | ANTIDEPRESSANTS | CIBA-GEIGY CORPORATION (US) | 1982-12-07 | — | — | US | disclosed |
| US-4316900-A | Piperazinopyrrolobenzodiazepines | CIBA-GEIGY CORPORATION (US) | 1982-02-23 | — | — | US | disclosed |
| EP-0001585-B1 | PIPERAZINO-PYRROLOBENZODIAZEPINES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1981-07-22 | — | — | EP | disclosed |
| EP-0001585-A1 | Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-05-02 | — | — | EP | disclosed |